IRVINE, Calif., April 27, 2020 (GLOBE NEWSWIRE) -- Edwards Lifesciences Corporation (NYSE: EW), the global leader in patient-focused innovations for structural heart disease and critical care ...
The above button links to Coinbase. Yahoo Finance is not a broker-dealer or investment adviser and does not offer securities or cryptocurrencies for sale or facilitate trading. Coinbase pays us for ...
Edwards Lifesciences Corporation, the global leader in patient-focused innovations for structural heart disease and critical care monitoring, has received CE Mark for its HemoSphere advanced ...
Edwards Lifesciences Corp.'s buy of Cas Medical Systems Inc. (Casmed) this spring appears to have borne fruit. The Irvine, Calif.-based company reported that the U.S. FDA has granted clearance for a ...
He quickly moved up to higher leadership roles within marketing and led various projects, including Edwards’ FloTrac Sensor and what’s now the HemoSphere monitor. Later on, he got the chance to work ...
The above button links to Coinbase. Yahoo Finance is not a broker-dealer or investment adviser and does not offer securities or cryptocurrencies for sale or facilitate trading. Coinbase pays us for ...
Edwards Lifesciences Corp. recently received FDA clearance for its ForeSight tissue oximetry device, its latest noninvasive medical device capable of measuring the oxygenation of brain tissue. The ...
IRVINE, Calif., April 18, 2019 /PRNewswire/ -- Edwards Lifesciences Corporation (NYSE: EW), the global leader in patient-focused innovations for structural heart disease and critical care monitoring, ...
Edwards Lifesciences has earned FDA clearance for its blood flow monitoring platform. CE-marked in January, the device tracks circulation and cardiac function, and helps physicians make treatment ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results